Abstract
This study determined the effects of the lipophobic electron acceptor, nitroblue tetrazolium (5 micromol/kg, i.v.) on the vasoconstrictor responses elicited by the 5-hydroxytryptamine2 (5-HT2) receptor agonist, alpha-methyl-5-HT (5-50 microg/kg, i.v.) and the alpha1-adrenoceptor agonist, phenylephrine (2.5-20 microg/kg, i.v.) in conscious Sprague-Dawley rats. The systemic injection of nitroblue tetrazolium elicited pronounced hemodynamic responses that subsided by 10-15 min. Prior to the administration of nitroblue tetrazolium, the injections of alpha-methyl-5-HT and phenylephrine elicited dose-dependent increases in mean arterial blood pressure and mesenteric, renal and hindquarter vascular resistances. After administration of nitroblue tetrazolium, the vasoconstrictor responses elicited by alpha-methyl-5-HT were augmented whereas those elicited by phenylephrine were diminished. These results are consistent with the possibility that nitroblue tetrazolium interacts with the extracellular ligand-binding domains of 5-HT2 receptors and alpha1-adrenoceptor and that this interaction has opposite effects on activities of these G protein coupled receptors.
References
Jan 1, 1976·Progress in Histochemistry and Cytochemistry·F P Altman
Jan 1, 1992·DNA and Cell Biology·W C ProbstS C Sealfon
Oct 1, 1992·Stroke; a Journal of Cerebral Circulation·W I Rosenblum
Jul 10, 1992·Brain Research·S T MellerG F Gebhart
Jan 1, 1991·Progress in Histochemistry and Cytochemistry·E Seidler
Oct 4, 1991·Brain Research·S T MellerG F Gebhart
Jan 1, 1991·Annual Review of Neuroscience·D Julius
May 10, 1990·Nature·P R MyersD G Harrison
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Jan 1, 1988·Annual Review of Pharmacology and Toxicology·N K Hollenberg
Feb 6, 1974·Histochemie. Histochemistry. Histochimie·F P Altman
Jan 1, 1970·Histochemie. Histochemistry. Histochimie·F P Altman
Jan 1, 1995·British Journal of Pharmacology·T J Williams, D E Clarke
Mar 1, 1994·Acta histochemica·E Seidler, C J van Noorden
Jan 1, 1994·Trends in Pharmacological Sciences·L EmorineA D Strosberg
Sep 7, 1993·European Journal of Pharmacology·R L DavissonS J Lewis
Aug 1, 1996·Circulation Research·R L DavissonS J Lewis
Sep 1, 1996·Hypertension·R L DavissonS J Lewis
Feb 5, 1999·European Journal of Pharmacology·N A BenkuskyN W Kooy
Apr 8, 1999·British Journal of Pharmacology·M L CohenD Calligaro
Nov 11, 1999·European Journal of Pharmacology·E J Whalen, S J Lewis
Aug 11, 2000·European Journal of Pharmacology·F S LambS J Lewis
Sep 16, 2000·Hypertension·E J WhalenS J Lewis
Nov 18, 2000·European Journal of Pharmacology·A HoqueS J Lewis
Nov 25, 2000·European Journal of Pharmacology·M D TravisS J Lewis
Sep 1, 1955·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·G H FINDLAY
Sep 14, 2004·Journal of Hypertension·Wendy W BatenburgA H Jan Danser
Jul 27, 2005·European Journal of Pharmacology·Stephen J LewisNeil W Kooy
Oct 13, 2005·Journal of Cardiovascular Pharmacology·Stephen J LewisJames N Bates